javlor 250mg10ml concentrate for solution for infusion vials
pierre fabre ltd - vinflunine ditartrate - solution for infusion - 25mg/1ml
javlor 50mg2ml concentrate for solution for infusion vials
pierre fabre ltd - vinflunine ditartrate - solution for infusion - 25mg/1ml
glytone skin lightening- hydroquinone cream
pierre fabre usa inc. - hydroquinone (unii: xv74c1n1ae) (hydroquinone - unii:xv74c1n1ae) - glytone skin lightening cream is indicated for the gradual lightening of hyperpigmented skin conditions such as chloasma, melasma, freckles, senile lentigines, and other unwanted areas of melanin hyperpigmentation. prior history of sensitivity or allergic reaction to this product or any of its ingredients. the safety of topical hydroquinone use during pregnancy or in children (12 years and under) has not been established.
glytone sunvanish skin lightening- hydroquinone cream
pierre fabre usa inc. - hydroquinone (unii: xv74c1n1ae) (hydroquinone - unii:xv74c1n1ae), avobenzone (unii: g63qqf2nox) (avobenzone - unii:g63qqf2nox), octinoxate (unii: 4y5p7mud51) (octinoxate - unii:4y5p7mud51), octocrylene (unii: 5a68wgf6wm) (octocrylene - unii:5a68wgf6wm), oxybenzone (unii: 95oos7ve0y) (oxybenzone - unii:95oos7ve0y) - glytone sunvanish is indicated for the gradual lightening of hyperpigmented skin conditions such as chloasma, melasma, freckles, senile lentigines, and other unwanted areas of melanin hyperpigmentation. prior history of sensitivity or allergic reaction to this product or any of its ingredients. the safety of topical hydroquinone use during pregnancy or in children (12 years and under) has not been established.
glytone skin lightening- hydroquinone gel
pierre fabre usa inc. - hydroquinone (unii: xv74c1n1ae) (hydroquinone - unii:xv74c1n1ae) - glytone skin lightening gel is indicated for the gradual lightening of hyperpigmented skin conditions such as chloasma, melasma, freckles, senile lentigines, and other unwanted areas of melanin hyperpigmentation. prior history of sensitivity or allergic reaction to this product or any of its ingredients. the safety of topical hydroquinone use during pregnancy or in children (12 years and under) has not been established.
navelbine 10 mg/ml concentrate for solution for infusion
pierre fabre ltd - vinorelbine tartrate - concentrate for solution for infusion - 10 base mg/ml - vinca alkaloids and analogues; vinorelbine
pectodrill sugar free for chesty coughs
pierre fabre medicament - carbocisteine - oral solution - 250/5 mg/ml - carbocisteine
navelbine
pierre fabre medicament 45 place abel gance, 92100 boulogne, france - vinorelbine tartrate - concentrate for solution for infusion - vinorelbine tartrate 10 mg/ml - antineoplastic agents
navelbine 10 mg/ml concentrate for solution for infusion
pierre fabre medicament - vinorelbine - concentrate for solution for infusion - 10 milligram(s)/millilitre - vinca alkaloids and analogues; vinorelbine
javlor
pierre fabre medicament australia pty ltd - vinflunine ditartrate -